Definitive Contract 75F40121C00127
Award Date
9/27/21
Potential Completion Date
9/28/23
Potential Value
$307K
Federal Agency
Food and Drug Administration
Awardee
The Johns Hopkins University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21205, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $911,251 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to The Johns Hopkins University to improve the efficiency and rigor of pharmacovigilance at the FDA. The contract involves developing a cognitive framework for case series evaluation and integrating it into the FDA's information visualization platform to support decision-making. This contract does not have a set-aside designation. The Johns Hopkins University, a private research university...
The U.S. Department of Health and Human Services Food and Drug Administration awarded a $347,261.89 firm fixed-price definitive contract to The Johns Hopkins University, a private research university, to evaluate device-related immune response unique to material and psychological location. This contract does not have a set-aside designation. The Johns Hopkins University is a well-established provider of biomedical research, public health initiatives, and scientific analysis services to federal...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order valued at three hundred forty-four thousand six hundred ninety-seven dollars and fifty cents ($344,697.50) to The Johns Hopkins University. The Johns Hopkins University will provide all deliverables to the Contracting Officer's Representative. Under this contract, Nanostring Technologies, Inc. was awarded a subcontract valued at an undisclosed amount to supply nCounter Master Kit...
This definitive cost-no-fee contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Monash University. The contract value is $399,988 to support a study titled "Bridging the Gap Between Urinary Tract Infection Pharmacokinetic/Pharmacodynamic In Vitro Models and the Optimization of Antibiotic Selection, Dosing Strategies, Clinical Breakpoints, and Novel Drug Development." This award was made under the FY23 FDA Broad Agency...
The U.S. Department of Health and Human Services (HHS) awarded a $18,000 firm fixed-price purchase order contract to The Johns Hopkins University, a private, non-profit research university located in Baltimore, Maryland. The contract, which does not have a set-aside designation, has an ultimate completion date of August 1, 2012. The contract supports the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), in its mission to...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $21,750 purchase order to Howard University for research services. The firm fixed price contract has a period of performance from April 2017 to April 2019. As the prime contractor, Howard University will perform the research services out of its division located in Silver Spring, Maryland. No additional details were provided regarding the scope of work, but the FDA funds various clinical trials and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $248,725 Firm Fixed Price contract to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking advanced research and development proposals to support regulatory science and innovation across multiple areas. Under this contract, Hartford Hospital is conducting comparative efficacy research on antibiotic...
This federal contract award, valued at $399,991.00, was issued by the U.S. Food and Drug Administration (FDA) to Midwestern University, a private non-profit educational institution, to develop and validate population pharmacokinetic models for beta-lactam antibiotics used in Continuous Renal Replacement Therapy (CRRT) for patients with hospital-acquired pneumonia. The contract was awarded under a Broad Agency Announcement (BAA) that sought research and development proposals to advance regulatory...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price definitive contract to the Maryland Department of Health's Prevention & Health Promotion Administration - Ideha Division to provide critical food inspection services in Baltimore, Maryland from August 2016 through September 2018. The contract had a ceiling value of $355,594.69. The contract work supports the FDA's role in ensuring food safety and public health through state-level collaboration and inspections. The...
This is a $1,999,999.99 cost-no-fee definitive contract awarded by the Defense Health Agency (DHA) to The Johns Hopkins University (JHU), a private research university in Baltimore, Maryland. The contract was awarded on September 30, 2016 with a completion date of December 29, 2020. The contract is not set-aside. According to the provided information, the contract supports biomedical research, public health initiatives, and applied studies to advance discovery and improve medical care. For...